shop now
clinical laboratory standards institute logo

 

News & Events

CLSI Releases Newborn Screening Document to Aid in the Detection of Severe Combined Immunodeficiency

Wayne, Pennsylvania, USA—May 2013—Clinical and Laboratory Standards Institute (CLSI) has released NBS06-A—Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline. Severe combined immunodeficiency (SCID) is a lethal disorder not evident at birth. This document addresses its detection by population-based newborn screening (NBS), which uses dried blood spot (DBS) specimens to measure T-cell receptor excision circles (TREC). TREC may be used to reveal the presence of SCID, and this presymptomatic detection is required for effective treatment.

Read More.

 

screen-shot-2017-01-11-at-4-44-33-pm

View Our Latest eNews

Access this month’s newsletter featuring the updates on all CLSI program areas.

Read Now

Sign Up For eNews Now!

Login


× five = 45


Register | Lost your password?